People's United Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,779
| Closed | -$319K | – | 646 |
|
|
2021
Q4 | $319K | Sell |
5,779
-916
| -14% | -$47.6K | 0.01% | 557 |
|
|
2021
Q3 | $320K | Buy |
6,695
+660
| +11% | +$33.2K | 0.01% | 600 |
|
|
2021
Q2 | $300K | Hold |
6,035
| – | – | 0.01% | 613 |
|
|
2021
Q1 | $269K | Sell |
6,035
-1,051
| -15% | -$47.7K | 0.01% | 613 |
|
|
2020
Q4 | $326K | Buy |
7,086
+107
| +2% | +$4.92K | 0.01% | 548 |
|
|
2020
Q3 | $328K | Buy |
6,979
+800
| +13% | +$40.1K | 0.01% | 505 |
|
|
2020
Q2 | $315K | Sell |
6,179
-1,957
| -24% | -$100K | 0.01% | 508 |
|
|
2020
Q1 | $385K | Buy |
8,136
+1,493
| +22% | +$79.6K | 0.01% | 424 |
|
|
2019
Q4 | $390K | Sell |
6,643
-194
| -3% | -$10.8K | 0.01% | 573 |
|
|
2019
Q3 | $365K | Sell |
6,837
-261
| -4% | -$13.4K | 0.01% | 596 |
|
|
2019
Q2 | $355K | Sell |
7,098
-10,307
| -59% | -$517K | 0.01% | 611 |
|
|
2019
Q1 | $909K | Sell |
17,405
-1,235
| -7% | -$61.7K | 0.03% | 408 |
|
|
2018
Q4 | $889K | Buy |
18,640
+4,301
| +30% | +$212K | 0.03% | 384 |
|
|
2018
Q3 | $720K | Sell |
14,339
-4,409
| -24% | -$224K | 0.02% | 428 |
|
|
2018
Q2 | $944K | Sell |
18,748
-1,792
| -9% | -$90.3K | 0.02% | 443 |
|
|
2018
Q1 | $1M | Sell |
20,540
-1,718
| -8% | -$80K | 0.03% | 364 |
|
|
2017
Q4 | $987K | Sell |
22,258
-3,144
| -12% | -$145K | 0.03% | 375 |
|
|
2017
Q3 | $1.29M | Sell |
25,402
-7,640
| -23% | -$388K | 0.04% | 304 |
|
|
2017
Q2 | $1.78M | Sell |
33,042
-12,671
| -28% | -$675K | 0.06% | 250 |
|
|
2017
Q1 | $2.41M | Sell |
45,713
-58,479
| -56% | -$2.97M | 0.08% | 194 |
|
|
2016
Q4 | $5.01M | Sell |
104,192
-1,064
| -1% | -$52.6K | 0.19% | 115 |
|
|
2016
Q3 | $5.67M | Buy |
105,256
+6,022
| +6% | +$330K | 0.3% | 85 |
|
|
2016
Q2 | $5.38M | Buy |
99,234
+11,858
| +14% | +$625K | 0.29% | 86 |
|
|
2016
Q1 | $4.43M | Buy |
87,376
+14,512
| +20% | +$723K | 0.23% | 98 |
|
|
2015
Q4 | $3.67M | Buy |
72,864
+352
| +0.5% | +$17.9K | 0.19% | 112 |
|
|
2015
Q3 | $3.48M | Buy |
72,512
+2,560
| +4% | +$133K | 0.2% | 112 |
|
|
2015
Q2 | $3.64M | Buy |
69,952
+414
| +0.6% | +$23.3K | 0.19% | 111 |
|
|
2015
Q1 | $4.01M | Buy |
69,538
+1,930
| +3% | +$111K | 0.2% | 114 |
|
|
2014
Q4 | $3.61M | Buy |
67,608
+5,646
| +9% | +$316K | 0.18% | 122 |
|
|
2014
Q3 | $3.56M | Buy |
61,962
+10,684
| +21% | +$655K | 0.19% | 116 |
|
|
2014
Q2 | $3.43M | Buy |
51,278
+20,365
| +66% | +$1.38M | 0.18% | 118 |
|
|
2014
Q1 | $2.06M | Buy |
30,913
+16,101
| +109% | +$1.09M | 0.12% | 138 |
|
|
2013
Q4 | $989K | Buy |
14,812
+572
| +4% | +$37.1K | 0.06% | 221 |
|
|
2013
Q3 | $893K | Buy |
14,240
+156
| +1% | +$10K | 0.06% | 205 |
|
|
2013
Q2 | $879K | Buy |
+14,084
| New | +$894K | 0.06% | 194 |
|
Other funds holding GSK
BCIM
JEST
People's United Financial's GSK Position: Q1 2022 in Review
People's United Financial sold out of GSK (GSK) in Q1 2022, closing a stake of 5,779 shares — an estimated $319K sold.
People's United Financial first reported a position in GSK in Q2 2013 and held it in 35 quarters. The position peaked at $5.67M in Q3 2016. 930 funds tracked by Wall St. Rank hold GSK as of Q1 2022.
- People's United Financial reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
- People's United Financial sold 5,779 GSK shares in Q1 2022, an estimated $319K.
- People's United Financial first reported a position in GSK in Q2 2013 and held it in 35 quarters.
- People's United Financial's GSK position peaked at $5.67M in Q3 2016.
- 930 funds tracked by Wall St. Rank held GSK as of Q1 2022.
Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.